Cytomegalovirus (CMV) infection is one of the most common complications affecting solid organ transplant recipients.

Background and aims: The risk of colorectal cancer is increased in ulcerative colitis (UC). Patients with UC have diverse colonoscopic appearances. Determining colonoscopic markers for cancer risk ...

Objective Vedolizumab is a gut-selective antibody to α4β7 integrin for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). We report an integrated summary of the safety of vedolizumab.

In June, 2025, 17 scientists from ten countries met at the International Agency for Research on Cancer (IARC) in Lyon, France, to finalise their evaluation of hepatitis D virus (HDV), human ...